Dermira’s Acne Medication Olumacostat Glaseretil Tanks in Two Phase III Trials Post author:Sam Post published:March 4, 2018 Post category:BioPharma Dermira plans to shutter the program and move on to more promising compounds. Source: BioSpace You Might Also Like Bristol-Myers Squibb's Opdivo Prevails in Phase III Melanoma Trial July 4, 2017 Johnson & Johnson Dissolves $700 Million R&D Deal With MacroGenics August 31, 2017 Flexion Eyes Creation of 100 New Sales Jobs to Sell Just-Approved Osteoarthritis Drug October 10, 2017
Flexion Eyes Creation of 100 New Sales Jobs to Sell Just-Approved Osteoarthritis Drug October 10, 2017